Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic background influences muscular dystrophy.

Ahlke Heydemann1, Jill M Huber, Alexis Demonbreun

  • 1Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.

Neuromuscular Disorders : NMD
|August 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

49-Year-Old Woman With Widespread Rash and Unilateral Vision Loss.

Mayo Clinic proceedings·2026
Same author

Excess muscle plasma membrane leak disrupts extracellular matrix content and shifts macrophage-mediated muscle repair.

JCI insight·2026
Same author

Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy.

Circulation research·2026
Same author

Motivations for pursuing multiple genetic risk assessments and responses to receiving identical risk results.

Journal of genetic counseling·2026
Same author

Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study.

American journal of human genetics·2026
Same author

The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments.

American journal of human genetics·2026

Genetic background significantly impacts muscular dystrophy severity. Researchers found that limb girdle muscular dystrophy (LGMD) caused by gamma-sarcoglycan mutations is less severe in some mouse strains, suggesting protective modifier genes.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuromuscular Disorders

Background:

  • Mutations in dystrophin-associated proteins, like sarcoglycans, cause muscular dystrophy.
  • Phenotypic variability in muscular dystrophy exists even with identical gene mutations.

Purpose of the Study:

  • To investigate the influence of genetic background on muscular dystrophy severity.
  • To identify genetic modifiers that affect the phenotype of limb girdle muscular dystrophy (LGMD).

Main Methods:

  • Engineered a mouse model with a gamma-sarcoglycan null allele.
  • Bred the mutation into four distinct genetic backgrounds (129SV/J, DBA/2J, etc.).
  • Quantified membrane permeability (Evan's blue dye uptake) and fibrosis (hydroxyproline content).

Related Experiment Videos

Main Results:

  • The gamma-sarcoglycan mutation severity varied significantly across genetic backgrounds.
  • DBA/2J mice exhibited the most severe phenotype, while 129SV/J mice showed the mildest.
  • Phenotype severity was independent of gender and age, and not linked to exercise levels.

Conclusions:

  • Genetic background plays a crucial role in modulating muscular dystrophy phenotypes.
  • The 129SV/J and C57B6/J strains possess modifier loci that suppress the muscular dystrophy phenotype.
  • Identifying these modifier genes could reveal novel therapeutic targets for muscular dystrophy.